CoChat

Microarray evaluation of specific IgE to allergen components in elite athletes

Bonini, M., Marcomini, L., Gramiccioni, C., Tranquilli, C., Melioli, G., Canonica, G. W., Bonini, S., on behalf of the ISAC Study Group · 2012 · Allergy
Cited by 26

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background: Allergic sensitization and diseases have been reported to have a very high and increasing prevalence in elite athletes. Over 80% of allergic athletes are poly‐sensitized. Objective: This study aims at evaluating the potential diagnostic added value of a microarray technology (Immuno CAP ISAC, P hadia AB [at present Thermo Fisher Scientific] U ppsala, Sweden which detects IgE antibodies to specific or cross‐reacting allergen components. Methods: Seventy‐two poly‐sensitized athletes according to skin prick test (SPT) with different allergic phenotypes (asthma n = 19; rhino‐conjunctivitis n = 20; food allergy and/or oral allergy syndrome n = 13; no clinical symptoms n = 20) and two different control populations (20 poly‐sensitized sedentary subjects with respiratory allergy and 20 healthy athletes with negative SPT) were studied for detecting specific IgE (sIgE) both to allergen extracts (I mmuno CAP s IgE) and to allergen components (I mmuno CAP ISAC). Results: Immuno CAP ISAC detected the presence of sIgE in 90% of poly‐sensitized athletes – in 96% with symptoms and in 75% without symptoms – and in 100% of allergic controls. The pattern of positivity towards the 103 components tested differed from subject to subject, even in those with the same sensitization to allergen extract SPT or sIgE. Based on the ISAC results, poly‐sensitized athletes were classified into the following prototypical patterns, differently represented in the clinical phenotypes studied (P = 0.03): (1) One single predominant specific allergen positivity; (2) sIgE to two or more non‐cross‐reacting allergens; (3) sIgE to cross‐reacting allergens; and (4) sIgE to components potentially responsible for severe allergic reactions. Conclusions: The Immuno CAP ISAC represents a useful additional tool for diagnosis and management of poly‐sensitized athletes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/all.12029

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 26

Metadata

Authors
Bonini, M., Marcomini, L., Gramiccioni, C., Tranquilli, C., Melioli, G., Canonica, G. W., Bonini, S., & on behalf of the ISAC Study Group
Venue
Allergy
Publisher
Wiley
Published
2012-10-04
Volume
67
Issue
12
Pages
1557-1564
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W1993793310
Cited by
26
References
2
FWCI
3.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.